Cite
APA Citation
Sands, B. E., Taub, P. R., Feagan, B. G., Armuzzi, A., Friedman, G. S., Moscariello, M., Lawendy, N., Pedersen, R. D., Chan, G., Nduaka, C. I., Quirk, D., Salese, L., & Su, C. (n.d.). oP033 The effect of tofacitinib on serum lipids and cardiovascular safety in patients with ulcerative colitis: results from the tofacitinib ulcerative colitis clinical programme. Journal of Crohn's and colitis, 12, S023. http://access.bl.uk/ark:/81055/vdc_100095482110.0x00000e